CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: All in all, by revealing an iNKT/innate CD8(+) T-cell axis with expected physiopathological relevance in CML, our findings should enhance understanding of the T cell components restored in CML treatment that contribute to disease control.